4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-22-017449
Chief Executive Officer bought 8,600 shares at $0.37 ($3,182)
From the SEC's structured data for this filing
Trades in this filing
Cohen Yuval · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-03-09 | Purchase : show line 1 in the form | +8,600 | $0.37 | $3,182 | 83,930 | D |
| Open-market purchases · 8,600 sh · avg $0.37 · $3,182 | ||||||
Loading xslF345X03/doc4.xml…